The Beijing Intellectual Property Court recently issued the first-ever decision in a dispute between a brand-name and a generic drug company under China’s newly-created patent linkage regime. Fang Qi and Danlei Wu of Fangda Partners examine the decision and its implications
Casper Sek of Jingtian & Gongcheng looks at the latest developments in China’s rules on cross-border transfers of personal information and finds that while this area has been a key area of focus for the authorities, a number of details are yet to be finalized
The head of the legal department at one of Asia’s top property developers discusses the state of China’s real estate sector and its likely future. Steady and environmentally sustainable growth is expected in the long term despite recent black swan events.
Danlei Wu of Fangda Partners shines a light on the Supreme People’s Court’s latest IP annual report, and shows how the SPC is leading the way in developing China's litigation landscape
Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector
Technical IP cases are handled by IP courts and intermediate people’s courts
Internet users shall be informed of the use of algorithmic recommendation
China allows for international design filings with the Hague System